Xenon CFO Sherry Aulin resigns; CEO Ian Mortimer appointed interim CFO

Xenon Pharmaceuticals Inc.

Sherry Aulin resigned as CFO, effective June 30, 2025.
Ian Mortimer (President & CEO) appointed interim CFO effective June 30, 2025, serving as principal financial and accounting officer.
No change to Mortimer's compensation in connection with the appointment.
Mortimer's background previously disclosed in the April 24, 2025 proxy statement.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.